Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|July 17, 2009
Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgeryBert Vander Cruyssen, Elisa Muñoz-Gomariz, Pilar Font, et al.
The Journal of Rheumatology|May 19, 2009
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcomeAnnelies Boonen, Bert vander Cruyssen, Kurt de Vlam, et al.
Annals of the Rheumatic Diseases|January 31, 2007
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practiceBert Vander Cruyssen, Clio Ribbens, Annelies Boonen, et al.
Rheumatology (Oxford, England)|November 14, 2019
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesAntoine Vanier, Josef S Smolen, Cornelia F Allaart, et al.
Rheumatology (Oxford, England)|July 15, 2016
Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristicsJoachim Sieper, Martin Rudwaleit, Jan Lenaerts, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE studyBernard Combe, Bhaskar Dasgupta, Ingrid Louw, et al.
Arthritis Care & Research|May 20, 2014
Patient and physician expectations of add-on treatment with golimumab for rheumatoid arthritis: relationships between expectations and clinical and quality of life outcomesBhaskar Dasgupta, Bernard Combe, Ingrid Louw, et al.
Annals of the Rheumatic Diseases|March 16, 2011
Predicting the outcome of ankylosing spondylitis therapyNathan Vastesaeger, Désirée van der Heijde, Robert D Inman, et al.
Arthritis Research & Therapy|September 19, 2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activityBert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2018
Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis: Results From Two Belgian Nationwide Axial Spondyloarthritis CohortsGaëlle Varkas, Nathan Vastesaeger, Heleen Cypers, et al.
Pageof 3